There's some big trouble to report at Boston-based Vertex, a bellwether company in the biotech industry.
The cystic fibrosis drug developer announced after the market closed Wednesday that they had ousted company COO and CFO Ian Smith for conduct unbecoming an executive at the company.
Ian Smith Handout photo
In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)
The best place to read Endpoints News? In your inbox.
Comprehensive daily news report for those who discover, develop, and market drugs. Join 42,100+ biopharma pros who read Endpoints News by email every day.Free Subscription